What should be the primary target of "treat to target" in psoriatic arthritis?
<h4>Background</h4> <p>Treat to Target in psoriatic arthritis (PsA) recommendations have stated that the target should be remission or inactive disease. Potential definitions include Very Low Disease Activity (VLDA), PsA Disease Activity Score (PASDAS) near remission, Disease Act...
Những tác giả chính: | Coates, LC, Lubrano, E, Perrotta, FM, Emery, P, Conaghan, PG, Helliwell, PS |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Journal of Rheumatology
2018
|
Những quyển sách tương tự
-
What should be the primary target of ‘treat to target’ in PsA?
Bằng: Coates, L, et al.
Được phát hành: (2018) -
Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
Bằng: Coates, L, et al.
Được phát hành: (2022) -
Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
Bằng: Coates, L, et al.
Được phát hành: (2019) -
Sustained very low disease activity and remission in psoriatic arthritis patients
Bằng: Lubrano, E, et al.
Được phát hành: (2019) -
New approved drugs for psoriatic arthritis
Bằng: F.M. Perrotta, et al.
Được phát hành: (2016-09-01)